|
CWC22 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.99840144432528E-15 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.003230E-01 |
| Stage1-vs-Stage3 |
3.161800E-02 |
| Stage1-vs-Stage4 |
3.104000E-02 |
| Stage2-vs-Stage3 |
9.724200E-01 |
| Stage2-vs-Stage4 |
7.212600E-01 |
| Stage3-vs-Stage4 |
6.663400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.68099994929594E-09 |
| Normal-vs-Asian |
9.4144692042164E-12 |
| Caucasian-vs-AfricanAmerican |
4.909200E-01 |
| Caucasian-vs-Asian |
1.117840E-01 |
| AfricanAmerican-vs-Asian |
6.549800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.062000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.46629999983905E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.693800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.021800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.972600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.570000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.555600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.431200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.501550E-02 |
| Classical-VS-Follicular |
2.216200E-01 |
| Classical-VS-Other |
9.901800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.630600E-01 |
| Tall-VS-Other |
2.089000E-01 |
| Tall-VS-Normal |
1.33226762955019E-15 |
| Follicular-VS-Other |
7.081400E-01 |
| Follicular-VS-Normal |
1.62725388719309E-12 |
| Other-VS-Normal |
3.760300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.10911280160053E-13 |
| N0-vs-N1 |
5.995000E-01 |
|
|
